semaglutide

For the first time in the history of obesity medicine, a drug has been shown to lower the risk of heart attack and stroke by 20%. For decades, doctors have helped patients reduce their cardiovascular risk by prescribing medications for hypertension and high cholesterol. We now know that treating obesity with medication is similarly compelling. […]

Wegovy Novo Nordisk has announced that they are no longer able to meet the demand in the US marketplace for Wegovy. To ensure people on Wegovy can get their medication, they are prioritizing access to the highest strengths (1.7 mg and 2.4 mg), and will be only producing limited amounts of the starting strengths (.25 […]